Are you Dr. Fontana?
Join over one million U.S. Physicians, Nurse Practitioners and PAs, already on Doximity.
- Gain access to free telehealth tools, such as our "call shielding" and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
You already have 59 invites waiting! - Read the latest clinical news, personalized to your specialty.
Office
4100 John R Hwcrc 4th Fl
Karmanos Cancer Center
Detroit, MI 48201Phone+1 800-527-6266Fax+1 313-576-8767
Summary
- Dr. Joseph Fontana, MD is an oncologist in Detroit, Michigan. He is currently licensed to practice medicine in Michigan and Maryland. He is affiliated with Karmanos Cancer Center, DMC Harper University Hospital, and John D. Dingell Department of Veterans Affairs Medical Center.
Education & Training
Case Western Reserve University/University Hospitals Cleveland Medical CenterInternship, Internal Medicine, 1975 - 1976
Perelman School of Medicine at the University of PennsylvaniaClass of 1975
Certifications & Licensure
MI State Medical License 1998 - 2023
MD State Medical License 1987 - 2000- American Board of Internal Medicine Internal Medicine
- American Board of Internal Medicine Hematology
- American Board of Internal Medicine Medical Oncology
Clinical Trials
- Docetaxel, Prednisone, and Pasireotide in Treating Patients With Metastatic Hormone-Resistant Prostate Cancer Start of enrollment: 2011 Oct 01
- Cabozantinib-S-Malate in Treating Patients With Hormone-Resistant Metastatic Prostate Cancer Start of enrollment: 2013 Mar 01
- LHRH Analogue Therapy With Enzalutamide or Bicalutamide in Treating Patients With Hormone Sensitive Prostate Cancer Start of enrollment: 2014 May 01
Publications & Presentations
PubMed
- 11 citationsPreclinical efficacy evaluations of XK-469: dose schedule, route and cross-resistance behavior in tumor bearing mice.Lisa Polin, Kathryn White, Juiwanna Kushner, Jennifer Paluch, Chiab Simpson
Investigational New Drugs. 2002-02-01 - 104 citationsClassical and novel retinoids: their targets in cancer therapyJoseph A. Fontana, Arun K. Rishi
Leukemia. 2002-04-01 - 168 citationsMechanisms of regulation of WAF1/Cip1 gene expression in human breast carcinoma: role of p53-dependent and independent signal transduction pathways.M. Saeed Sheikh, Xiao Su Li, Jian Chyi Chen, Zhi Ming Shao, Jose V. Ordonez
Oncogene. 1994-12-01
Grant Support
- Human Leukemia Growth Inhibition By A Novel RetinoidNational Cancer Institute2004–2008
- Induction Of Apoptosis In Breast CancerNational Cancer Institute1999–2002
- Phase II Clinical Trials Of New Chemopreventive AgentsDivision Of Cancer Prevention And Control1998
- Induction Of Apoptosis In Breast CancerNational Cancer Institute1997–1998
- Retinoid Inhibition Of Breast Cancer GrowthNational Cancer Institute1994–1997
- The Role Of C AMP In Leukemic Cell DifferentiationNational Cancer Institute1985
Professional Memberships
- Member
